Article
Human mesenchymal stromal cell therapy for damaged cochlea repair in nod-scid mice deafened with kanamycin.
Cytotherapy - 1 Feb 2018
Bettini Simone, Franceschini Valeria, Astolfi Laura, Simoni Edi, Mazzanti Benedetta, Martini Alessandro, Revoltella Roberto P
Abstract excerpt
BACKGROUND: Kanamycin, mainly used in the treatment of drug-resistant-tuberculosis, is known to cause irreversible hearing loss. Using the xeno-transplant model, we compared both in vitro and in vivo characteristics of human mesenchymal stromal cells (MSCs) derived from adult tissues, bone marrow (BM-MSCs) and adipose tissue (ADSCs). These tissues were selected for their availability, in vitro multipotency and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
